# Vir Biotechnology, Inc.: Form 8-K, filed Sep 10, 2024

- Company: [Vir Biotechnology, Inc.](/companies/vir.md) (CIK 1706431)
- Form: 8-K
- Filed: 2024-09-10
- Accepted by EDGAR: Sep 10, 2024, 08:10 ET
- Period: 2024-09-06
- Accession: 0001628280-24-039948
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1706431/000162828024039948/vir-20240906.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1706431/000162828024039948/

## Items reported

- Item 2.01: Completion of an acquisition or disposition
- Item 5.02: Departure or appointment of officers or directors
- Item 7.01: Regulation FD disclosure
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1706431/000162828024039948/vir-20240906.htm

Filed Sep 10, 2024.
Source: SEC EDGAR, the filing index for accession 0001628280-24-039948. Last ingested by Listed: Nov 4, 2026, 15:14 ET. No prices; not investment advice.